Comparison of the US and Australian cystic fibrosis registries: The impact of newborn screening

Pediatrics

Volumn 129, Issue 2, 2012, Pages

  Martin, Bradley ^a,b   Schechter, Michael S ^c   Jaffe, Adam ^a,b   Cooper, Peter ^d   Bell, Scott C ^e,f,g   Ranganathan, Sarath ^h,i,j,k  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c EMORY UNIVERSITY   (United States)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^e THE PRINCE CHARLES HOSPITAL   (Australia)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g Queensland Children's Medical Research Institute   (Australia)

^h ROYAL CHILDREN'S HOSPITAL   (Australia)

ⁱ BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^j MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^k UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

Cystic fibrosis; Lung function; Newborn screening

Indexed keywords

PANCREAS ENZYME;

AGE; ARTICLE; AUSTRALIA; BODY MASS; CLINICAL PRACTICE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE REGISTRY; EXPIRATORY RESERVE VOLUME; FEASIBILITY STUDY; FEMALE; FORCED EXPIRATORY VOLUME; GENDER; GENOTYPE; HUMAN; LUNG FIBROSIS; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN SCREENING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; UNITED STATES;

AGE FACTORS; AUSTRALIA; BENCHMARKING; BODY MASS INDEX; CROSS-CULTURAL COMPARISON; CYSTIC FIBROSIS; FEASIBILITY STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMANS; INFANT, NEWBORN; MALE; NEONATAL SCREENING; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY IMPROVEMENT; REGISTRIES; SEX FACTORS; UNITED STATES;

EID: 84856541302     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-0567     Document Type: Article

References (23)

1. Davies JC, Alton EWFW and Bush A. Cystic Fibrosis. BMJ. 2007;335:1255-1259
2. Cystic Fibrosis Foundation Patient Registry Annual Data Report 2009. Cystic Fibrosis Foundation 2011. Available at: www.cff.org/LivingWithCF/ CareCenterNetwork/PatientRegistry/. Accessed February 4, 2011
3. Australian Cystic Fibrosis Data Registry. Cystic Fibrosis in Australia: Annual Report of the Australian Cystic Fibrosis Data Registry 2009. North Ryde, New South Wales, Australia: Cystic Fibrosis Australia; 2011
4. Wilcken B, Brown AR, Urwin R, Brown DA. Cystic fibrosis screening by dried blood spot trypsin assay: results in 75,000 newborn infants. J Pediatr. 1983;102(3):383-387 (Pubitemid 13149459)
5. Massie J, Clements B; Australian Paediatric Respiratory Group. Diagnosis of cystic fibrosis after newborn screening: the Australasian experience - twenty years and five million babies later: a consensus statement from the Australasian Paediatric Respiratory Group. Pediatr Pulmonol. 2005;39(5):440-446 (Pubitemid 40548286)
6. Grosse SD, Boyle CA, Botkin JR, et al CDC. Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR Recomm Rep. 2004;53(RR-13):1-36
7. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data. 2000;(314):1-27
8. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis. 1983;127(6):725-734 (Pubitemid 13101554)
9. Padman R, McColley SA, Miller DP, et al Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function. Pediatrics. 2007;119(3). Available at: www.pediatrics.org/cgi/ content/full/119/3/e531
10. Johnson C, Butler SM, Konstan MW, Morgan W, Wohl ME. Factors influencing outcomes in cystic fibrosis: a center-based analysis. Chest. 2003;123(1):20-27 (Pubitemid 36126709)
11. Australian Government Department of Health and Ageing Pharmaceutical Benefits Scheme. Available at: www.pbs.gov.au/medicine/item/5704F-6120D. Accessed December 21, 2011
12. Schechter MS. Non-genetic influences on cystic fibrosis lung disease: the role of sociodemographic characteristics, environmental exposures, and healthcare interventions. Semin Respir Crit Care Med. 2003;24(6):639-652 (Pubitemid 38036759)
13. United Nations Demographic and Social Statistics. Available at: http://unstats.un.org/unsd/demographic/products/socind/health.htm
14. McKone EF, Goss CH, Aitken ML. CFTR genotype as a predictor of prognosis in cystic fibrosis. Chest. 2006;130(5):1441-1447 (Pubitemid 44786738)
15. Schechter MS, Shelton BJ, Margolis PA, Fitzsimmons SC. The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med. 2001;163(6):1331-1337 (Pubitemid 32506595)
16. O'Connor GT, Quinton HB, Kneeland T, et al. Median household income and mortality rate in cystic fibrosis. Pediatrics. 2003;111 (4 pt 1). Available at: www.pediatrics.org/cgi/content/full/111/4/SE1/e333
17. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002;34(2):91-100 (Pubitemid 34809519)
18. McCormick J, Sims EJ, Green MW, Mehta G, Culross F, Mehta A. Comparative analysis of Cystic Fibrosis Registry data from the UK with USA, France and Australasia. J Cyst Fibros. 2005;4(2):115-122 (Pubitemid 40867761)
19. McCormick J, Mehta G, Olesen HV, Viviani L, Macek M, Jr;Mehta A European Registry Working Group. Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis. Lancet. 2010;375(9719):1007- 1013
20. Mehta G, Jr;Macek M, Jr;Mehta A European Registry Working Group. Cystic fibrosis across Europe: EuroCareCF analysis of demographic data from 35 countries. J Cyst Fibros. 2010;9(suppl 2):S5-S21
21. Stern M, Lindblad A, Viviani L, Ravilly S, Olesen H. ECFS Registry Definition Consensus Meeting - Århus 2007. Available at: www.ecfs.eu/files/webfm/webfiles/File/ecfs-registry/ ecfs-registry-definition- consensus-meeting.pdf. Accessed December 21, 2011
22. Sims G. International benchmarking from centre-level cystic fibrosis data. Pediatr Pulmonol. 2010;45(S33):410
23. Brennan S, Gangell C, Wainwright C, Sly PD. Disease surveillance using bronchoalveolar lavage. Paediatr Respir Rev. 2008;9(3):151-159